# Larimar Therapeutics, Inc.: filings

LRMR · Nasdaq · CIK 1374690 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lrmr.md) · [Financials](/companies/lrmr/financials.md) · [Filings](/companies/lrmr/filings.md) · [Insiders](/companies/lrmr/insiders.md)

## Reports and events: 238 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 228, 8-K 147, SC 13G/A 45, 10-Q 37, 3 34, SC 13G 29, S-8 17, 10-K 12, DEF 14A 12, CORRESP 11, UPLOAD 11, 424B5 10, SC 13D/A 10, EFFECT 8, SCHEDULE 13G/A 8, DEFA14A 7, S-1/A 7, D 6, S-3 6, 8-K/A 5, ARS 4, SC 13D 3, SCHEDULE 13G 3, 424B4 2, 4/A 2, PRE 14A 2, PRER14A 2, S-1 2, S-1MEF 2, SCHEDULE 13D/A 2, 10-K/A 1, 144 1, 8-A12B 1, CERTNAS 1, CT ORDER 1, D/A 1, DEFM14A 1, DRS 1, DRS/A 1, PREM14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 20:06 ET | [8-K](/filings/0001193125-26-407331.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-407331 |
| 2026-08-04 | 11:12 ET | [10-Q](/filings/0001193125-26-331529.md) | Quarterly report, period 2026-06-30 | 0001193125-26-331529 |
| 2026-08-04 | 11:02 ET | [8-K](/filings/0001193125-26-331516.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-331516 |
| 2026-06-29 | 10:33 ET | [8-K](/filings/0001193125-26-286780.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286780 |
| 2026-05-19 | 20:27 ET | [8-K](/filings/0001193125-26-230852.md) | 5.07 Shareholder vote results | 0001193125-26-230852 |
| 2026-05-14 | 20:18 ET | [10-Q](/filings/0001193125-26-224087.md) | Quarterly report, period 2026-03-31 | 0001193125-26-224087 |
| 2026-05-14 | 11:02 ET | [8-K](/filings/0001193125-26-222746.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-222746 |
| 2026-04-20 | 20:06 ET | [DEF 14A](/filings/0001193125-26-163942.md) | Proxy statement, period 2026-04-17 | 0001193125-26-163942 |
| 2026-03-19 | 19:41 ET | [10-K](/filings/0001193125-26-115878.md) | Annual report, period 2025-12-31 | 0001193125-26-115878 |
| 2026-03-19 | 11:04 ET | [8-K](/filings/0001193125-26-115119.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115119 |
| 2026-03-09 | 20:08 ET | [8-K](/filings/0001193125-26-098493.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-098493 |
| 2026-03-02 | 00:46 ET | [SCHEDULE 13D/A](/filings/0001193805-26-000206.md) | Ownership report, active investor, amended | 0001193805-26-000206 |
| 2026-02-27 | 22:48 ET | [8-K](/filings/0001193125-26-077646.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-077646 |
| 2026-02-24 | 12:02 ET | [8-K](/filings/0001193125-26-065186.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-065186 |
| 2026-01-22 | 12:00 ET | [8-K](/filings/0001193125-26-018664.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-018664 |
| 2026-01-12 | 21:18 ET | [8-K](/filings/0001193125-26-010409.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010409 |
| 2025-12-17 | 13:00 ET | [8-K](/filings/0001193125-25-321738.md) | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-321738 |
| 2025-11-10 | 12:01 ET | [8-K](/filings/0001193125-25-273217.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-273217 |
| 2025-11-05 | 21:15 ET | [10-Q](/filings/0001193125-25-266969.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266969 |
| 2025-11-05 | 12:03 ET | [8-K](/filings/0001193125-25-265702.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265702 |
| 2025-10-14 | 11:00 ET | [8-K](/filings/0001193125-25-237998.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-237998 |
| 2025-09-29 | 11:00 ET | [8-K](/filings/0001193125-25-221538.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221538 |
| 2025-08-14 | 19:36 ET | [10-Q](/filings/0000950170-25-108797.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108797 |
| 2025-08-14 | 11:02 ET | [8-K](/filings/0000950170-25-108409.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-108409 |
| 2025-07-31 | 22:26 ET | [SCHEDULE 13D/A](/filings/0001193805-25-001138.md) | Ownership report, active investor, amended | 0001193805-25-001138 |
| 2025-07-31 | 10:05 ET | [8-K](/filings/0001193125-25-169818.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-169818 |
| 2025-07-29 | 21:01 ET | [8-K](/filings/0001193125-25-168096.md) | 2.02 Results of operations | 0001193125-25-168096 |
| 2025-06-23 | 21:13 ET | [8-K](/filings/0000950170-25-089074.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-089074 |
| 2025-06-23 | 11:02 ET | [8-K](/filings/0000950170-25-088704.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088704 |
| 2025-05-13 | 20:03 ET | [8-K](/filings/0000950170-25-070287.md) | 5.07 Shareholder vote results | 0000950170-25-070287 |
| 2025-05-05 | 10:33 ET | [8-K](/filings/0000950170-25-063125.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-063125 |
| 2025-04-30 | 21:06 ET | [10-Q](/filings/0000950170-25-061222.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061222 |
| 2025-04-30 | 11:01 ET | [8-K](/filings/0000950170-25-060563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-060563 |
| 2025-04-11 | 11:42 ET | [DEF 14A](/filings/0000950170-25-053028.md) | Proxy statement, period 2025-04-09 | 0000950170-25-053028 |
| 2025-03-24 | 20:51 ET | [10-K](/filings/0000950170-25-043925.md) | Annual report, period 2024-12-31 | 0000950170-25-043925 |
| 2025-03-24 | 11:03 ET | [8-K](/filings/0000950170-25-043487.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043487 |
| 2025-01-27 | 21:11 ET | [8-K](/filings/0000950170-25-009196.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-009196 |
| 2025-01-10 | 12:22 ET | [8-K](/filings/0000950170-25-003794.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003794 |
| 2024-12-16 | 12:02 ET | [8-K](/filings/0000950170-24-136384.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-136384 |
| 2024-11-18 | 12:02 ET | [8-K](/filings/0000950170-24-127768.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-127768 |
| 2024-10-30 | 21:03 ET | [10-Q](/filings/0000950170-24-119100.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119100 |
| 2024-10-30 | 11:03 ET | [8-K](/filings/0000950170-24-118586.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-118586 |
| 2024-08-08 | 18:38 ET | [10-Q](/filings/0000950170-24-093733.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093733 |
| 2024-08-07 | 11:02 ET | [8-K](/filings/0000950170-24-092265.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-092265 |
| 2024-06-10 | 10:05 ET | [8-K](/filings/0000950170-24-071056.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-071056 |
| 2024-05-31 | 20:07 ET | [8-K](/filings/0000950170-24-067306.md) | 5.07 Shareholder vote results | 0000950170-24-067306 |
| 2024-05-30 | 20:08 ET | [8-K](/filings/0000950170-24-066571.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-066571 |
| 2024-05-20 | 20:08 ET | [8-K](/filings/0000950170-24-062387.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-062387 |
| 2024-05-09 | 20:11 ET | [10-Q](/filings/0000950170-24-056965.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056965 |
| 2024-05-09 | 11:02 ET | [8-K](/filings/0000950170-24-056248.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-056248 |

Page 1 of 5. [Older](/companies/lrmr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.